PHAT (Phathom Pharmaceuticals) FCF Margin %: -26.94% (As of Mar. 2026)


PHAT Phathom Pharmaceuticals Inc PHAT
25 GF Score
Price $10.61
! 3 Warning Signs
View Full Analysis

What is Phathom Pharmaceuticals FCF Margin %?

Phathom Pharmaceuticals PHAT -2.30% 25 FCF Margin % is -26.94% as of Mar. 2026. GuruFocus rates PHAT with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Phathom Pharmaceuticals ranks better than 54.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Phathom Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-15.7 Mil. Phathom Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $58.3 Mil. Therefore, Phathom Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -26.94%.

As of today, Phathom Pharmaceuticals's current FCF Yield % is -11.55%.

The historical rank and industry rank for Phathom Pharmaceuticals's FCF Margin % or its related term are showing as below:

PHAT' s FCF Margin % Range Over the Past 10 Years
Min: -20412.61   Med: -483.07   Max: -47.71
Current: -47.71

During the past 8 years, the highest FCF Margin % of Phathom Pharmaceuticals was -47.71%. The lowest was -20412.61%. And the median was -483.07%.

PHAT's FCF Margin % is ranked better than
54.69% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs PHAT: -47.71

Phathom Pharmaceuticals FCF Margin % Related Terms

Phathom Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Phathom Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phathom Pharmaceuticals FCF Margin % Chart

Phathom Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -20,412.61 -483.07 -95.37

Phathom Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -297.86 -159.04 -28.57 -8.84 -26.94

PHAT vs AURA, RLMD, SMNR: FCF Margin % Comparison

For the Biotechnology subindustry, Phathom Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phathom Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Phathom Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Phathom Pharmaceuticals's FCF Margin % falls into.


PHAT
25GF Score
Phathom Pharmaceuticals Inc PHAT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phathom Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Phathom Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-167.004/175.11
=-95.37 %

Phathom Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-15.708/58.301
=-26.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -26.94% mean?
Phathom Pharmaceuticals (PHAT) has a FCF Margin % of -26.94% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phathom Pharmaceuticals and its competitors. According to the industry distribution chart, Phathom Pharmaceuticals ranks #435 out of 960 companies in the Biotechnology industry, placing it in the top 45.3%.
Is Phathom Pharmaceuticals' FCF Margin % too high?
Phathom Pharmaceuticals' current FCF Margin % is -26.94%. Based on the distribution chart, Phathom Pharmaceuticals ranks #435 out of 960 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Phathom Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Phathom Pharmaceuticals' FCF Margin % compare to AURA and RLMD?
According to the Biotechnology industry distribution chart, Phathom Pharmaceuticals ranks #435 out of 960 companies for FCF Margin %. This puts Phathom Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phathom Pharmaceuticals and its competitors. Phathom Pharmaceuticals's current FCF Margin % is -26.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phathom Pharmaceuticals stock overvalued right now?
Phathom Pharmaceuticals (PHAT) has a current FCF Margin % of -26.94%. The current FCF Margin % is -26.94%. Phathom Pharmaceuticals' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Phathom Pharmaceuticals (PHAT), the current FCF Margin % is -26.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phathom Pharmaceuticals Business Description

Address 100 Campus Drive, Suite 102, Florham Park, NJ, USA, 07932
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
25GF Score

Get the complete analysis for PHAT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.61
Price